Beijing, February 24, 2025 – A newly identified bat coronavirus, designated HKU5-CoV-2, has been found to enter human cells using the same cell-surface protein as SARS-CoV-2, the virus responsible for COVID-19, according to a study published in the journal Cell.
While the virus possesses key features such as a furin cleavage site that facilitates entry via the ACE2 receptor, researchers noted that it does not infect human cells as efficiently as SARS-CoV-2.
In laboratory experiments, HKU5-CoV-2 successfully infected human cells with high ACE2 levels in both test tube assays and in models simulating human intestinal and airway tissues. The study further identified several monoclonal antibodies and antiviral drugs capable of targeting the bat virus, offering potential avenues for preemptive therapeutic strategies.
The research has attracted significant market attention; Bloomberg reported that news of the study influenced a modest rise in shares of several COVID vaccine manufacturers, including Pfizer, Moderna, and Novavax. However, infectious disease expert Dr. Michael Osterholm from the University of Minnesota cautioned that the reaction might be “overblown.” He pointed to the extensive preexisting immunity in the global population against similar SARS viruses and the markedly lower binding affinity of HKU5-CoV-2 to human ACE2 compared with SARS-CoV-2, factors that could mitigate the pandemic risk.
While the discovery highlights a potential pathway for zoonotic spillover, the authors of the study stressed that several suboptimal factors for human adaptation suggest that the risk of this bat virus emerging as a human pathogen should not be exaggerated. The findings add to the growing body of research on coronaviruses and underscore the importance of continued surveillance of wildlife pathogens.
Read next
16:58
COVID-19
Pakistani President Asif Ali Zardari has tested positive for COVID-19, according to his doctor, Asim Hussain. The 70-year-old leader has been advised to remain in isolation as a precautionary measure, while his condition is reported to be improving.
10:43
Australia
Australia is facing the continued emergence of new SARS-CoV-2 variants more than five years after COVID-19 was declared a pandemic.
05:22
Measles cases in the European region surged to a 25-year high in 2024, more than doubling from the previous year, the World Health Organisation (WHO) and UNICEF reported on Thursday, urging immediate action to restore vaccination levels that declined after the COVID-19 pandemic.
16:46
Revenue decline
BioNTech forecasts a revenue decline for 2025, expecting between 1.7 billion and 2.2 billion euros, down from 2.75 billion euros last year. This drop is due to Pfizer write-downs and stable vaccination rates. BioNTech also plans significant job cuts and new hires.
10:22
The World Health Organization's Director-General, Tedros Adhanom Ghebreyesus, has expressed confidence that a global pandemic agreement will be finalized by May 2025, despite concerns over US participation under President-elect Donald Trump.
What is your opinion on this topic?
Leave the first comment